ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 77 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 2.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $402,000 | +83.6% | 291,384 | +126.7% | 0.00% | – |
| Q1 2021 | $219,000 | +29.6% | 128,529 | -5.6% | 0.00% | – |
| Q4 2020 | $169,000 | +267.4% | 136,175 | +325.7% | 0.00% | – |
| Q3 2020 | $46,000 | +39.4% | 31,989 | +18.8% | 0.00% | – |
| Q2 2020 | $33,000 | +10.0% | 26,916 | +7.5% | 0.00% | – |
| Q1 2020 | $30,000 | -44.4% | 25,035 | -2.5% | 0.00% | – |
| Q4 2019 | $54,000 | -5.3% | 25,689 | 0.0% | 0.00% | – |
| Q3 2019 | $57,000 | +26.7% | 25,689 | +19.4% | 0.00% | – |
| Q2 2019 | $45,000 | -54.5% | 21,523 | -15.9% | 0.00% | – |
| Q3 2018 | $99,000 | +110.6% | 25,606 | +85.8% | 0.00% | – |
| Q2 2018 | $47,000 | -52.5% | 13,781 | -70.9% | 0.00% | – |
| Q1 2018 | $99,000 | -96.2% | 47,331 | -90.1% | 0.00% | -100.0% |
| Q3 2014 | $2,615,000 | +96.2% | 476,200 | +266.3% | 0.00% | – |
| Q2 2014 | $1,333,000 | -14.6% | 130,000 | 0.0% | 0.00% | – |
| Q1 2014 | $1,561,000 | – | 130,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |